TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED

Income Statement Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

Stocks

600329

CNE000001808

Pharmaceuticals

End-of-day quote Shanghai S.E. Other stock markets 12/06/2026			5-day change	1st Jan Change
38.30 ^CNY	+2.11%		-3.36%	-16.05%

05-20	Chinese State-Backed Entities to Dispose of Stake in Tianjin Pharmaceutical Da Ren Tang Unit via Public Tender	MT
05-15	Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Announces Appointment of Zhai Shuping as Independent and Non-Executive Director, Effective May 15, 2026	CI

67ead6cf3ddcb08f85e.svvas_sFmhIXT2LFSYAKepuI3wgUH_3Ek5dBMQV2a8A.iqPvi55p4EhNdymmAsE-OenSt2ohUryR2Pw3RmMfGobxv7H4sHbCYVEXVg

Published financial data: TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	6.89B	8.23B	8.21B	7.29B	4.9B
Other Revenues, Total	15.33M	17.87M	16.23M	14.25M	20.73M
Total Revenues	6.91B	8.25B	8.22B	7.31B	4.92B
Cost of Goods Sold, Total	4.16B	4.99B	4.63B	3.8B	1.31B
Gross Profit	2.75B	3.26B	3.59B	3.5B	3.6B
Selling General & Admin Expenses, Total	1.93B	2.35B	2.51B	2.46B	2.42B
Provision for Bad Debts	4.89M	9.22M	19.09M	44.78M	7.41M
R&D Expenses	161M	153M	185M	162M	190M
Other Operating Expenses	64.12M	76.69M	79.05M	63.44M	72.77M
Other Operating Expenses, Total	2.16B	2.59B	2.79B	2.73B	2.69B
Operating Income	587M	671M	799M	774M	918M
Interest Expense, Total	-2.94M	-10.27M	-35.85M	-40.2M	-9.16M
Interest And Investment Income	264M	330M	363M	1.94B	1.69B
Net Interest Expenses	261M	320M	327M	1.9B	1.68B
Currency Exchange Gains (Loss)	688K	-2.44M	-1.13M	-1.51M	-801K
Other Non Operating Income (Expenses)	-5.3M	3.08M	-1.73M	-2.55M	-2.08M
EBT, Excl. Unusual Items	843M	992M	1.12B	2.67B	2.59B
Impairment of Goodwill	-	-19.57M	-18.78M	-53.61M	-12.3M
Gain (Loss) On Sale Of Investments	-	-	-	-	-
Gain (Loss) On Sale Of Assets	10.39M	671K	-481K	72.75K	2.64M
Asset Writedown	-	-180K	-24.95M	-60.16M	-105M
Other Unusual Items	18.96M	7.23M	16.27M	26.13M	8.95M
EBT, Incl. Unusual Items	873M	980M	1.1B	2.58B	2.49B
Income Tax Expense	85.93M	107M	127M	364M	377M
Earnings From Continuing Operations	787M	873M	969M	2.22B	2.11B
Net Income to Company	787M	873M	969M	2.22B	2.11B
Minority Interest	-17.73M	-11.46M	18M	14.12M	20.27M
Net Income - (IS)	769M	862M	987M	2.23B	2.13B
Net Income to Common Incl Extra Items	769M	862M	987M	2.23B	2.13B
Net Income to Common Excl. Extra Items	769M	862M	987M	2.23B	2.13B
Per Share Items
Net EPS - Basic	1	1.12	1.28	2.9	2.77
Basic EPS - Continuing Operations	1	1.12	1.28	2.9	2.77
Basic Weighted Average Shares Outstanding	769M	769M	771M	769M	769M
Net EPS - Diluted	1	1.11	1.28	2.89	2.77
Diluted EPS - Continuing Operations	1	1.11	1.28	2.89	2.77
Diluted Weighted Average Shares Outstanding	769M	776M	771M	771M	769M
Normalized Basic EPS	0.66	0.79	0.93	2.19	2.13
Normalized Diluted EPS	0.66	0.78	0.93	2.18	2.13
Dividend Per Share	0.5	1.12	1.28	1.28	4.79
Payout Ratio	30.17	44.96	88.91	45.33	46.05
Supplemental Items
EBITDA	699M	784M	924M	893M	1.03B
EBITA	593M	677M	819M	791M	935M
EBIT	587M	671M	799M	774M	918M
EBITDAR	705M	792M	933M	901M	1.03B
Total Revenues (As Reported)	6.91B	8.25B	8.22B	7.31B	4.92B
Effective Tax Rate - (Ratio)	9.85	10.91	11.56	14.1	15.14
Total Current Taxes	75.05M	163M	186M	412M	409M
Total Deferred Taxes	10.88M	-56.4M	-58.98M	-48.78M	-32.35M
Normalized Net Income	509M	609M	720M	1.68B	1.64B
Interest Capitalized	4.96M	5.41M	3.62M	-	-
Supplemental Operating Expense Items
Advertising Expense	-	405M	-	445M	-
Marketing Expenses	758M	998M	-	-	-
Selling and Marketing Expenses	1.56B	1.97B	2.13B	2B	2.03B
General and Administrative Expenses	373M	378M	382M	459M	391M
Research And Development Expense From Footnotes	161M	153M	185M	162M	190M
Net Rental Expense, Total	5.65M	7.96M	9.62M	7.34M	7.19M
Imputed Operating Lease Interest Expense	8.32M	6.41M	10.01M	12.49M	9.22M
Imputed Operating Lease Depreciation	-2.67M	1.54M	-388K	-5.16M	-2.03M
Stock-Based Comp., Other (Total)	10.15M	6.82M	18.98M	23.52K	-
Total Stock-Based Compensation	10.15M	6.82M	18.98M	23.52K	-

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	2.28B	2.88B	2.13B	2.94B	1.02B
Short Term Investments	110M	-	61.7M	1B	3.32B
Trading Asset Securities, Total	-	-	-	-	-
Total Cash And Short Term Investments	2.39B	2.88B	2.19B	3.94B	4.33B
Accounts Receivable, Total	1.97B	2.72B	2.65B	1.32B	1.57B
Other Receivables	40.73M	60.54M	34.1M	8.56M	10.29M
Notes Receivable	-	-	-	-	22.94M
Total Receivables	2.01B	2.79B	2.69B	1.32B	1.6B
Inventory	1.53B	1.43B	1.57B	1.29B	1.13B
Other Current Assets, Total	496M	148M	111M	52.96M	84.57M
Total Current Assets	6.42B	7.25B	6.55B	6.61B	7.15B
Gross Property Plant And Equipment	2.69B	2.77B	2.85B	2.84B	2.55B
Accumulated Depreciation	-1.2B	-1.3B	-1.41B	-1.44B	-1.41B
Net Property Plant And Equipment	1.49B	1.46B	1.44B	1.39B	1.14B
Long-term Investments	741M	801M	883M	1.29B	2.59B
Goodwill	-	84.69M	65.91M	12.3M	-
Other Intangibles, Total	198M	281M	318M	295M	293M
Deferred Tax Assets Long-Term	155M	208M	266M	314M	341M
Deferred Charges Long-Term	12.31M	11M	18.3M	66.07M	52.83M
Other Long-Term Assets, Total	49.92M	60.31M	686M	785M	114M
Total Assets	9.07B	10.16B	10.23B	10.77B	11.69B
Liabilities
Accounts Payable, Total	1.24B	1.41B	1.13B	285M	189M
Accrued Expenses, Total	680M	1.17B	1.49B	1.79B	1.92B
Short-term Borrowings	-	102M	81.8M	21.65M	57.9M
Current Portion of Long-Term Debt	30M	-	-	-	-
Current Portion of Leases	1.6M	4.1M	3.56M	1.33M	3.12M
Current Income Taxes Payable	9.53M	93.28M	76.68M	298M	29.22M
Unearned Revenue Current, Total	216M	219M	146M	123M	150M
Other Current Liabilities	255M	339M	306M	303M	2.16B
Total Current Liabilities	2.43B	3.33B	3.23B	2.82B	4.51B
Long-Term Debt	10M	161M	251M	10M	10M
Long-Term Leases	1.57M	871K	2.74M	5.6M	4.66M
Unearned Revenue Non Current	59.15M	59.88M	57.14M	55.14M	45.49M
Deferred Tax Liability Non Current	4.21M	8.82M	7.33M	6.04M	276K
Other Non Current Liabilities	44.42M	40.73M	33.69M	24.07M	22.93M
Total Liabilities	2.55B	3.61B	3.58B	2.92B	4.59B
Common Stock, Total	773M	773M	770M	770M	770M
Additional Paid In Capital	1.37B	1.05B	975M	975M	975M
Retained Earnings	4.22B	4.7B	4.83B	6.07B	5.33B
Treasury Stock	-32.03M	-29.75M	-7.04M	-	-
Comprehensive Income and Other	30.62M	29.53M	34.34M	26.93M	24.07M
Total Common Equity	6.36B	6.52B	6.6B	7.84B	7.1B
Minority Interest	149M	30.49M	44.55M	6.34M	446K
Total Equity	6.51B	6.55B	6.65B	7.85B	7.1B
Total Liabilities And Equity	9.07B	10.16B	10.23B	10.77B	11.69B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	773M	773M	770M	770M	767M
ECS Total Common Shares Outstanding	773M	773M	770M	770M	767M
Book Value / Share	8.23	8.43	8.57	10.19	9.26
Tangible Book Value	6.17B	6.16B	6.22B	7.54B	6.81B
Tangible Book Value Per Share	7.97	7.96	8.07	9.79	8.87
Total Debt	43.17M	268M	339M	38.59M	75.68M
Net Debt	-2.35B	-2.61B	-1.85B	-3.91B	-4.26B
Debt Equivalent Oper. Leases	45.21M	63.64M	76.98M	58.71M	57.48M
Minority Interest, Total (Incl. Fin. Div)	149M	30.49M	44.55M	6.34M	446K
Equity Method Investments, Total	730M	760M	882M	1.29B	1.17B
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	600M	494M	823M	736M	625M
Inventories - Work In Process, Total	148M	144M	154M	162M	144M
Inventories - Finished Goods, Total	793M	822M	653M	473M	473M
Inventories - Others	31.06M	34.21M	20.34M	1.75M	1.5M
Buildings, Total	1.32B	1.34B	1.34B	1.33B	1.1B
Machinery, Total	1.03B	1.09B	1.11B	1.07B	1.05B
Full Time Employees	4.65K	4.91K	4.62K	-	3.89K
Accumulated Allowance for Doubtful Accounts (Supple)	137M	154M	165M	99.07M	106M

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	769M	862M	987M	2.23B	2.13B
Depreciation & Amortization - CF	107M	108M	108M	107M	93.75M
Amortization of Goodwill and Intangible Assets - (CF)	6.22M	5.87M	19.52M	16.89M	17.57M
Depreciation & Amortization, Total	114M	114M	128M	124M	111M
Amortization of Deferred Charges, Total - (CF)	4.18M	6.37M	5.37M	4.65M	13.72M
(Gain) Loss From Sale Of Asset	-12.32M	-1.08M	-149K	-109K	-2.83M
(Gain) Loss on Sale of Investments - (CF)	-213M	-274M	-308M	-1.91B	-1.65B
Asset Writedown & Restructuring Costs	1.93M	20.16M	44.36M	114M	118M
Provision and Write-off of Bad Debts	4.89M	9.22M	19.09M	44.78M	7.41M
Other Operating Activities, Total	32.68M	54.02M	38.92M	39.39M	16.59M
Change In Accounts Receivable	-42.07M	-732M	74.01M	26.25M	-260M
Change In Inventories	-47.4M	58.87M	-165M	21.95M	118M
Change In Accounts Payable	220M	610M	-56.06M	289M	-113M
Change In Deferred Taxes	10.88M	-56.4M	-59.13M	-59.63M	-32.35M
Change in Other Net Operating Assets	10.15M	6.82M	-18.98M	-23.52K	-
Cash from Operations	852M	677M	688M	925M	461M
Capital Expenditure	-157M	-108M	-141M	-118M	-119M
Sale of Property, Plant, and Equipment	28.71M	1.49M	186K	79.08K	391K
Cash Acquisitions	-	-47.61M	-	-	-
Divestitures	-	-	-	-348M	0
Investment in Marketable and Equity Securities, Total	-335M	-65.08M	-606M	451M	-1.31B
Other Investing Activities, Total	151M	207M	178M	357M	20.66M
Cash from Investing	-312M	-12.28M	-569M	342M	-1.41B
Short Term Debt Issued, Total	-	-	-	-	-
Long-Term Debt Issued, Total	-	206M	871M	1.22B	5M
Total Debt Issued	-	206M	871M	1.22B	5M
Short Term Debt Repaid, Total	-	-	-	-	-
Long-Term Debt Repaid, Total	-1.42M	-39.87M	-807M	-522M	-4.6M
Total Debt Repaid	-1.42M	-39.87M	-807M	-522M	-4.6M
Issuance of Common Stock	-	-	-	-	-
Repurchase of Common Stock	-1.35M	-	-22.67M	-282K	-
Common Dividends Paid	-232M	-387M	-877M	-1.01B	-981M
Common & Preferred Stock Dividends Paid	-232M	-387M	-877M	-1.01B	-981M
Other Financing Activities, Total	-9.87M	-14.96M	2.7M	-7.79M	-
Cash from Financing	-245M	-237M	-834M	-320M	-981M
Foreign Exchange Rate Adjustments	-	5.98K	45.34K	-42.09K	-216K
Net Change in Cash	296M	428M	-714M	947M	-1.93B
Supplemental Items
Cash Income Tax Paid (Refund)	497M	527M	766M	752M	1.21B
Levered Free Cash Flow	160M	927M	366M	1.82B	2.07B
Unlevered Free Cash Flow	161M	934M	388M	1.84B	2.07B
Change In Net Working Capital	176M	-495M	123M	-1.35B	-1.49B
Net Debt Issued / Repaid	-1.42M	166M	63.52M	699M	405K

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	4.23	4.37	4.9	4.61	5.11
Return on Total Capital	5.85	6.27	7.24	6.51	7.62
Return On Equity %	12.63	13.37	14.68	30.56	28.24
Return on Common Equity	12.64	13.38	15.04	30.87	28.52
Margin Analysis
Gross Profit Margin %	39.76	39.49	43.66	47.94	73.31
SG&A Margin	27.94	28.45	30.5	33.65	49.15
EBITDA Margin %	10.12	9.5	11.23	12.22	20.87
EBITA Margin %	8.59	8.21	9.96	10.82	19.02
EBIT Margin %	8.5	8.14	9.72	10.59	18.67
Income From Continuing Operations Margin %	11.39	10.59	11.78	30.32	42.92
Net Income Margin %	11.13	10.45	12	30.51	43.34
Net Avail. For Common Margin %	11.13	10.45	12	30.51	43.34
Normalized Net Income Margin	7.37	7.38	8.76	23	33.37
Levered Free Cash Flow Margin	2.31	11.24	4.45	24.88	42.02
Unlevered Free Cash Flow Margin	2.34	11.32	4.72	25.22	42.14
Asset Turnover
Asset Turnover	0.8	0.86	0.81	0.7	0.44
Fixed Assets Turnover	4.69	5.59	5.66	5.15	3.88
Receivables Turnover (Average Receivables)	3.5	3.51	3.05	3.67	3.39
Inventory Turnover (Average Inventory)	2.76	3.38	3.09	2.67	1.09
Short Term Liquidity
Current Ratio	2.64	2.17	2.03	2.35	1.59
Quick Ratio	1.81	1.7	1.51	1.87	1.31
Operating Cash Flow to Current Liabilities	0.35	0.2	0.21	0.33	0.1
Days Sales Outstanding (Average Receivables)	104.36	104.1	119.6	99.61	107.63
Days Outstanding Inventory (Average Inventory)	132.15	108.02	118.04	137.23	336.33
Average Days Payable Outstanding	93.24	98.72	96.89	73.28	66.56
Cash Conversion Cycle (Average Days)	143.28	113.4	140.74	163.56	377.4
Long Term Solvency
Total Debt/Equity	0.66	4.09	5.1	0.49	1.07
Total Debt / Total Capital	0.66	3.93	4.86	0.49	1.05
LT Debt/Equity	0.18	2.48	3.82	0.2	0.21
Long-Term Debt / Total Capital	0.18	2.38	3.63	0.2	0.2
Total Liabilities / Total Assets	28.16	35.49	35.04	27.1	39.26
EBIT / Interest Expense	199.87	65.38	22.29	19.26	100.17
EBITDA / Interest Expense	238.55	76.51	25.86	22.33	112.32
(EBITDA - Capex) / Interest Expense	185.12	66	21.93	19.4	99.38
Total Debt / EBITDA	0.06	0.34	0.37	0.04	0.07
Net Debt / EBITDA	-3.35	-3.33	-1.99	-4.35	-4.14
Total Debt / (EBITDA - Capex)	0.08	0.4	0.43	0.05	0.08
Net Debt / (EBITDA - Capex)	-4.32	-3.86	-2.35	-5.01	-4.67
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	4.6	19.42	-0.33	-11.14	-32.7
Gross Profit, 1 Yr. Growth %	6.46	18.59	10.21	-2.42	2.9
EBITDA, 1 Yr. Growth %	5.82	11.78	17.48	-5.75	14.61
EBITA, 1 Yr. Growth %	6.08	13.78	20.51	-6.16	17.91
EBIT, 1 Yr. Growth %	6.53	14.36	19.06	-5.72	18.58
Earnings From Cont. Operations, 1 Yr. Growth %	15.77	10.98	10.93	128.68	-4.72
Net Income, 1 Yr. Growth %	16.24	12.05	14.49	125.94	-4.41
Normalized Net Income, 1 Yr. Growth %	15.41	19.46	18.26	129.26	-2.35
Diluted EPS Before Extra, 1 Yr. Growth %	16.28	11	15.32	125.78	-4.15
Accounts Receivable, 1 Yr. Growth %	-0.01	38.26	-2.62	-50.38	19.37
Inventory, 1 Yr. Growth %	2.51	-6.27	9.59	-17.93	-11.88
Net Property, Plant and Equip., 1 Yr. Growth %	1.83	-1.46	-1.58	-3.33	-18.08
Total Assets, 1 Yr. Growth %	9.46	12.02	0.72	5.26	8.55
Tangible Book Value, 1 Yr. Growth %	10	-0.17	1	21.22	-9.68
Common Equity, 1 Yr. Growth %	9.57	2.47	1.21	18.83	-9.49
Cash From Operations, 1 Yr. Growth %	26.95	-20.55	1.66	34.3	-50.14
Capital Expenditures, 1 Yr. Growth %	-17.03	-31.25	30.61	-16.4	0.68
Levered Free Cash Flow, 1 Yr. Growth %	-41.09	520.52	-61.95	404.39	13.69
Unlevered Free Cash Flow, 1 Yr. Growth %	-40.41	517.23	-59.89	381.42	12.45
Dividend Per Share, 1 Yr. Growth %	66.67	124	14.29	0	274.22
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-0.62	11.77	9.1	-5.89	-22.67
Gross Profit, 2 Yr. CAGR %	-3.02	12.37	14.32	3.7	0.21
EBITDA, 2 Yr. CAGR %	5.75	8.91	14.76	6.59	4.07
EBITA, 2 Yr. CAGR %	5.23	10.04	17.29	7.89	5.35
EBIT, 2 Yr. CAGR %	5.42	10.38	16.68	7.38	5.73
Earnings From Cont. Operations, 2 Yr. CAGR %	11.29	13.35	10.95	59.27	47.61
Net Income, 2 Yr. CAGR %	10.88	14.12	13.26	60.84	46.96
Normalized Net Income, 2 Yr. CAGR %	7.54	17.42	18.89	66.13	49.62
Diluted EPS Before Extra, 2 Yr. CAGR %	11.11	13.61	13.14	61.36	47.11
Accounts Receivable, 2 Yr. CAGR %	4.71	17.58	16.03	-30.49	-23.04
Inventory, 2 Yr. CAGR %	-2.2	-1.98	1.35	-5.16	-14.96
Net Property, Plant and Equip., 2 Yr. CAGR %	4.26	0.17	-1.52	-2.46	-11.01
Total Assets, 2 Yr. CAGR %	7.52	10.73	6.22	2.97	6.9
Tangible Book Value, 2 Yr. CAGR %	8.75	4.79	0.41	10.65	4.64
Common Equity, 2 Yr. CAGR %	8.68	5.96	1.84	9.67	3.71
Cash From Operations, 2 Yr. CAGR %	31.16	0.43	-10.13	16.85	-18.17
Capital Expenditures, 2 Yr. CAGR %	-12.63	-24.47	-5.24	4.49	-8.26
Levered Free Cash Flow, 2 Yr. CAGR %	-33.85	85.02	56.43	37.51	139.46
Unlevered Free Cash Flow, 2 Yr. CAGR %	-33.75	85.66	60.17	38	132.67
Dividend Per Share, 2 Yr. CAGR %	29.1	93.22	60	6.9	93.45
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	2.8	5.66	7.58	1.89	-15.84
Gross Profit, 3 Yr. CAGR %	1.59	3.71	11.64	8.45	3.44
EBITDA, 3 Yr. CAGR %	10.43	7.82	11.8	8.4	9.3
EBITA, 3 Yr. CAGR %	9.7	8.12	13.55	9.94	11.25
EBIT, 3 Yr. CAGR %	9.83	8.32	13.2	9.66	10.99
Earnings From Cont. Operations, 3 Yr. CAGR %	11.49	11.18	12.54	41.2	34.2
Net Income, 3 Yr. CAGR %	11.05	11.27	14.25	42.58	35.23
Normalized Net Income, 3 Yr. CAGR %	10.03	11.37	17.72	48.86	39.17
Diluted EPS Before Extra, 3 Yr. CAGR %	11.06	11.07	14.17	42.44	35.64
Accounts Receivable, 3 Yr. CAGR %	4.91	14.88	10.42	-12.58	-16.76
Inventory, 3 Yr. CAGR %	4.71	-3.58	1.74	-5.53	-7.46
Net Property, Plant and Equip., 3 Yr. CAGR %	7.4	2.32	-0.42	-2.13	-7.97
Total Assets, 3 Yr. CAGR %	8.47	9	7.29	5.9	4.8
Tangible Book Value, 3 Yr. CAGR %	9.06	5.69	3.51	6.92	3.41
Common Equity, 3 Yr. CAGR %	8.91	6.57	4.35	7.21	2.87
Cash From Operations, 3 Yr. CAGR %	34.52	10.98	0.84	2.75	-12.03
Capital Expenditures, 3 Yr. CAGR %	-3.71	-19.34	-9.35	-9.12	3.2
Levered Free Cash Flow, 3 Yr. CAGR %	25.6	36.49	10.52	129.96	29.06
Unlevered Free Cash Flow, 3 Yr. CAGR %	22.57	36.42	12.73	130.08	28.9
Dividend Per Share, 3 Yr. CAGR %	31.48	55.13	62.19	36.8	62.32
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	2.05	7.71	5.28	0.88	-5.73
Gross Profit, 5 Yr. CAGR %	6.39	8.16	6.51	3.7	6.92
EBITDA, 5 Yr. CAGR %	16.15	14.19	12.2	7.39	9.2
EBITA, 5 Yr. CAGR %	17.3	14.98	12.75	8.1	10.84
EBIT, 5 Yr. CAGR %	17.62	15.19	12.52	7.94	10.74
Earnings From Cont. Operations, 5 Yr. CAGR %	13.99	13.03	11.28	28.37	25.44
Net Income, 5 Yr. CAGR %	12.67	12.6	11.93	28.94	26.35
Normalized Net Income, 5 Yr. CAGR %	12.15	12.53	13.49	30.71	30.04
Diluted EPS Before Extra, 5 Yr. CAGR %	12.7	12.35	11.89	28.97	26.36
Accounts Receivable, 5 Yr. CAGR %	6.19	12.4	9.23	-6.04	-4.43
Inventory, 5 Yr. CAGR %	10.42	5.29	3.35	-4.21	-5.3
Net Property, Plant and Equip., 5 Yr. CAGR %	8.35	6.37	3.74	0.38	-4.8
Total Assets, 5 Yr. CAGR %	7.07	8.93	7.56	6.55	7.13
Tangible Book Value, 5 Yr. CAGR %	9.02	7.45	5.52	7.64	3.96
Common Equity, 5 Yr. CAGR %	8.76	7.81	6.02	7.8	4.1
Cash From Operations, 5 Yr. CAGR %	15.33	179.47	14.48	13.29	-7.24
Capital Expenditures, 5 Yr. CAGR %	5.84	-1.17	-4.33	-10.54	-8.91
Levered Free Cash Flow, 5 Yr. CAGR %	-11.77	45.51	35.33	37.88	50.13
Unlevered Free Cash Flow, 5 Yr. CAGR %	-12.18	46.97	34.65	38.03	50.22
Dividend Per Share, 5 Yr. CAGR %	14.87	41.14	42.22	33.66	74.04